Search tips
Search criteria 


Logo of bmjcredLink to Publisher's site
Br Med J (Clin Res Ed). 1987 April 4; 294(6576): 866–868.
PMCID: PMC1245926

Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine.


Thirty five homosexual men (17 positive for antibody to the human immunodeficiency virus (HIV) and 18 consistently negative) were vaccinated against hepatitis B virus infection. Eight of the 17 seropositive patients failed to develop detectable hepatitis B surface antibody within three months of the third injection compared with only one of the 18 seronegative patients (p less than 0.01). HIV infection is prevalent in the developed world in groups at risk for hepatitis B infection and in certain Third World countries where widespread vaccination programmes exist. This study shows the impact that coincident HIV infection may have on an otherwise efficacious vaccine. The efficacy of this and other vaccines in patients infected with HIV needs to be studied urgently.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (692K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. [PubMed]
  • Mann JM, Francis H, Davachi F, Baudoux P, Quinn TC, Nzilambi N, Bosenge N, Colebunders RL, Piot P, Kabote N, et al. Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. Lancet. 1986 Sep 20;2(8508):654–657. [PubMed]
  • Melbye M, Njelesani EK, Bayley A, Mukelabai K, Manuwele JK, Bowa FJ, Clayden SA, Levin A, Blattner WA, Weiss RA, et al. Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet. 1986 Nov 15;2(8516):1113–1115. [PubMed]
  • Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981 Sep-Oct;1(5):377–385. [PubMed]
  • Coutinho RA, Lelie N, Albrecht-Van Lent P, Reerink-Brongers EE, Stoutjesdijk L, Dees P, Nivard J, Huisman J, Reesink HW. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J (Clin Res Ed) 1983 Apr 23;286(6374):1305–1308. [PMC free article] [PubMed]
  • Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, Denis F, Mar ID. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet. 1981 Feb 7;1(8215):289–292. [PubMed]
  • Crosnier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet. 1981 Feb 28;1(8218):455–459. [PubMed]
  • Desmyter J, Colaert J, De Groote G, Reynders M, Reerink-Brongers EE, Lelie PN, Dees PJ, Reesink HW. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial. Lancet. 1983 Dec 10;2(8363):1323–1328. [PubMed]
  • Mulley AG, Silverstein MD, Dienstag JL. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. [PubMed]
  • Adler MW, Belsey EM, McCutchan JA, Mindel A. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1621–1624. [PMC free article] [PubMed]
  • Carne CA, Weller IV, Johnson AM, Loveday C, Pearce F, Hawkins A, Smith A, Williams P, Tedder RS, Adler MW. Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet. 1987 Mar 21;1(8534):656–658. [PubMed]
  • Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR Morb Mortal Wkly Rep. 1985 Mar 1;34(8):105–113. [PubMed]
  • Cameron CH, Combridge BS, Howell DR, Barbara JA. A sensitive immunoradiometric assay for the detection of hepatitis B surface antigen. J Virol Methods. 1980;1(6):311–323. [PubMed]
  • Tedder RS, Cameron CH, Wilson-Croome R, Howell DR, Colgrove A, Barbara JA. Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol. 1981;6(4):323–332. [PubMed]
  • Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O'Malley PM, Penley KA, Altman NL, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. [PubMed]
  • Krugman S, Holley HP, Jr, Davidson M, Simberkoff MS, Matsaniotis N. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses. J Med Virol. 1981;8(2):119–121. [PubMed]
  • Courouce AM, Jungers P, Benhamou E, Laplanche A, Crosnier J. Hepatitis B vaccine in dialysis patients. N Engl J Med. 1984 Dec 6;311(23):1515–1516. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group